Showing results (331-340 of 989) with videos related to
Sort By:
Pageof 99
Therapeutic Advances in Respiratory Disease|September 28, 2019
DT-0111: a novel drug-candidate for the treatment of COPD and chronic coughAmir Pelleg, Fadi Xu, Jianguo Zhuang, et al.Therapeutic Advances in Respiratory Disease|August 9, 2019
Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive reviewLuis Máiz Carro, Miguel A Martínez-GarcíaTherapeutic Advances in Respiratory Disease|March 12, 2011
The role of monoclonal antibodies in the treatment of severe asthmaLouanne M Tourangeau, Arthur Kavanaugh, Stephen I WassermanTherapeutic Advances in Respiratory Disease|March 25, 2011
COPD: a multifactorial systemic diseaseAlice Huertas, Paolo PalangeTherapeutic Advances in Respiratory Disease|October 19, 2010
The pathogenesis of idiopathic pulmonary fibrosisWilliam R Coward, Gauri Saini, Gisli JenkinsTherapeutic Advances in Respiratory Disease|October 8, 2010
Retinoid treatment of Emphysema in Patients on the Alpha-1 International Registry. The REPAIR study: study design, methodology and quality control of study assessmentsJan Stolk, Brendan G Cooper, Berend Stoel, et al.Therapeutic Advances in Respiratory Disease|November 10, 2010
The impact of psychological distress on exacerbation rates in COPDCatherine Laurin, Grégory Moullec, Simon L Bacon, et al.Therapeutic Advances in Respiratory Disease|November 20, 2010
The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational studyRoberto Dal Negro, Luca Bonadiman, Silvia Tognella, et al.Therapeutic Advances in Respiratory Disease|May 5, 2012
Patient and provider perceptions of sleep disordered breathing assessment during prenatal care: a survey-based observational studyGhada Bourjeily, Christina Raker, Michael J Paglia, et al.Therapeutic Advances in Respiratory Disease|February 23, 2012
Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapyJuan Carlos Barros-Tizón, María Luisa Torres, Ignacio Blanco, et al.Pageof 99